| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |